期刊文献+

术前NLR-PLR评分对乳腺癌患者预后的影响及相关因素分析 被引量:3

Effect of preoperative NLR-PLR score on the prognosis of breast cancer patients and analysis of related factors
下载PDF
导出
摘要 目的分析术前外周血中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)联合评分对乳腺癌患者预后的影响及其与临床病理学参数的相关性。方法选择行根治性乳腺癌手术的患者304例。利用受试者工作特征(ROC)曲线确定NLR及PLR临界值,采用Kaplan-Meier法绘制生存曲线,采用COX回归模型进行单因素和多因素分析,基于生存结局绘制ROC曲线,并对NLR-PLR评分和单一炎症指标的预后价值进行比较。结果NLR-PLR评分与乳腺癌患者的年龄(P=0.022)、月经状态(P=0.026)、肿瘤大小(P=0.041)、TNM分期(P=0.028)、淋巴结转移(P=0.042)和术后放疗(P=0.002)有关。NLR-PLR评分为0分的患者生存时间与评分为1分、2分的患者生存时间比较,差异均有统计学意义(χ20,1=8.540,P=0.003;χ20,2=22.382,P<0.001);NLR-PLR评分为1分的患者生存时间与NLR-PLR评分为2分的患者生存时间比较,差异有统计学意义(χ21,2=4.279,P=0.039)。单因素分析结果显示肿瘤大小、TNM分期、雌激素受体(ER)、孕激素受体(PR)、淋巴结转移、NLR-PLR评分是影响乳腺癌患者预后的相关因素(P<0.05);多因素分析结果显示TNM分期、淋巴结转移、NLR-PLR评分是乳腺癌患者预后的独立影响因素(P<0.05)。NLR-PLR评分的ROC曲线下面积(AUC)大于NLR、PLR和LMR单一炎症指标的AUC(P<0.001)。结论NLR-PLR评分与乳腺癌患者临床病理学参数密切相关,是乳腺癌患者预后的独立影响因素,NLR-PLR评分越高的患者生存时间越短。 Objective To investigate the effect of the combined score of neutrophil-to-lymphocyte ratio(NLR)and platelet-to-lymphocyte ratio(PLR)in the preoperative peripheral blood on the prognosis of breast cancer patients and its correlation with clinicopathological parameters.Methods A total of 304 patients who underwent radical breast cancer surgery were selected.The critical values of NLR and PLR were determined by receiver operating characteristic(ROC)curve.The survival curve was drawn by Kaplan-Meier method.The univariate and multivariate analysis were performed by COX regression model,and the ROC curve was drawn based on the survival outcome.And the prognostic value of NLR-PLR score and single inflammatory index were compared.Results The NLR-PLR score was related to the age(P=0.022),menstrual status(P=0.026),tumor size(P=0.041),TNM stage(P=0.028),lymph node metastasis(P=0.042)and postoperative radiotherapy(P=0.002)of breast cancer patients.There were statistically significant differences in the survival time of patients with NLR-PLR score of 0 and that of patients with scores of 1 and 2(χ20,1=8.540,P=0.003;χ20,2=22.382,P<0.001).There was statistically significant difference between the survival time of patients with NLR-PLR score of 1 and that of patients with NLR-PLR score of 2(χ21,2=4.279,P=0.039).The results of univariate analysis showed that tumor size,TNM stage,estrogen receptor(ER),progesterone receptor(PR),lymph node metastasis,and NLR-PLR score were the related factors affecting the prognosis of breast cancer patients(P<0.05),while the results of multivariate analysis showed that TNM stage,lymph node metastasis,and NLR-PLR score were the independent factors affecting the prognosis of breast cancer patients(P<0.05).The area under curve(AUC)of ROC of NLR-PLR score was larger than the AUC of the single inflammatory index of NLR,PLR and LMR(P<0.001).Conclusion NLR-PLR score is closely related to the clinicopathological parameters of breast cancer patients,and it is an independent factor affecting the prognosis of breast cancer patients.The higher the NLR-PLR score,the shorter the survival time of patients.
作者 张媚粼 王梦晗 郑昂 金锋 ZHANG Mei-lin;WANG Meng-han;ZHENG Ang;JIN Feng(Department of Breast Surgery,First Hospital of China Medical University,Shenyang Liaoning 110001,China)
出处 《局解手术学杂志》 2021年第5期390-394,共5页 Journal of Regional Anatomy and Operative Surgery
基金 国家自然科学基金(82073282) 国家自然科学基金(81773163) 中国博士后科学基金面上资助项目(2020M681018)。
关键词 中性粒细胞与淋巴细胞比值 血小板与淋巴细胞比值 乳腺癌 预后 neutrophil-to-lymphocyte ratio platelet-to-lymphocyte ratio breast cancer prognosis
  • 相关文献

参考文献9

二级参考文献44

  • 1赵跃,郭永刚,孙甲甲,刘春蓉,周广磊,黄景昊,王宁,吴凤云.术前SII、NLR、PLR在分化型甲状腺癌中的诊断价值分析[J].兰州大学学报(医学版),2018,0(6):50-56. 被引量:10
  • 2[1]MESSMORE H.Hemostasis in malignancy[J].Am J Haemato,1990,35(1):4546.
  • 3[2]POLITE BN,LAMONT EB.Are venous thromboembolic events associated with subsequent breast and colorectal carcinoma diagnoses in the elderly? A case-control study of Medicare beneficiaries[J].Cancer,2006,106(4):923-930.
  • 4[3]MEHTA P.Potential role of platelet in the pathogenesis of tumor metastasis[J].Blood,1981,63 (1):55-58.
  • 5[5]FALANGA A,LEVINE MN.The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer:results from a randomized trial[J].Thromb Haemost,1998,79(1):23-27.
  • 6[6]WADA H,SASE T,YAMAGUCHI M.Hypercoagulant states in malignant lymphoma[J].Exp Oncol,2005,27 (3):17-21.
  • 7[7]SAMAMA MM,HORELLOU MH,ELALAMY I,et al.D-dimer levels,constitutional thrombophilia,and venous thrombosis prediction:clinical aspects and implications[J].Semin Vasc Med,2005,5(4):371-377.
  • 8陈创奇,方乐堃,马晋平,蔡世荣,董文广,黄奕华,何裕隆,詹文华.结直肠癌2042例临床病理特点及预后回归分析[J].中华医学杂志,2010,90(26):1804-1807. 被引量:33
  • 9吴彪,王春友.SIRS患者炎症因子变化与病情相关性的研究[J].中国现代普通外科进展,2011,14(6):501-502. 被引量:12
  • 10陈琼,刘志才,程兰平,宋国慧,孙喜斌,郑荣寿,张思维,陈万青.2003~2007年中国结直肠癌发病与死亡分析[J].中国肿瘤,2012,21(3):179-182. 被引量:357

共引文献711

同被引文献20

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部